CaSR has been shown to be involved in Alzheimer’s Disease, asthma, and cancer
| Inventor | Institute |
|---|---|
| R. Tyler Miller | University of Florida Research Foundation |
| SKU: | 158407 |
|---|---|
| Product description: | Calcium-sensing receptor (CaSR) is a GPCR sensing extracellular levels of calcium ions and is primarily expressed in the renal tubes of the kidney and in the parathyroid gland. Mutations have been known to cause several disorders such as familial hypocalciuris hypercalemia, autosomal dominant hypocalcemia and Type 6 Bartter syndrome. CaSR has also been shown to be involved in Alzheimer's Disease, asthma, and cancer. CaSR has been shown to interaction with filamin, which is not present in certain types of cancers, and can only activate ERK in the presence of filamin. |
| Alternate name: | CaSR, CaR |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 kappa |
| Immunogen: | Synthetic peptide corresponding to amino acids 15-29 in the extracellular amino terminus of human CaSR |
| Cat. #: | 158407 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell signaling and signal transduction;Tissue-specific biology |
| Application: | WB ; IHC ; IP |
| Target: | Calcium Sensing Receptor (CaSR) |
| Reactivity: | Human ; Mouse ; Rat ; Rabbit |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Calcium-sensing receptor (CaSR) is a GPCR sensing extracellular levels of calcium ions and is primarily expressed in the renal tubes of the kidney and in the parathyroid gland. Mutations have been known to cause several disorders such as familial hypocalciuris hypercalemia, autosomal dominant hypocalcemia and Type 6 Bartter syndrome. CaSR has also been shown to be involved in Alzheimer's Disease, asthma, and cancer. CaSR has been shown to interaction with filamin, which is not present in certain types of cancers, and can only activate ERK in the presence of filamin. |
|---|
| Format: | Liquid |
|---|---|
| Storage conditions: | -20° C |
| Shipping conditions: | Dry ice |
| References: |
Awata et al. 2001. J Biol Chem. 276(37):34871-9. PMID: 11390379. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.